Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Photosynth, 76% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
4379 Photosynth inc. 【J-GAAP】
Earnings ReportPhotosynth inc. <4379> [TSE Growth] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit/loss for the fiscal year ending December 2024 turned into a profit of 91 million yen (compared to a loss of 222 million yen in the previous period), exceeding the previous forecast of 70 million yen. In the fiscal year ending December 2025, the consolidated ordinary profit is expected to expanded to 75.8% to 160 million yen, marking the second consecutive term of record-high profits.
In the most recent three-month period, from October to December (4Q), the consolidated ordinary loss improved to a deficit of 23 million yen (compared to a loss of 88 million yen in the same period last year). The operating profit/loss margin drastically improved from -12.2% in the same period last year to -4.3%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 1,994 | -609 | -600 | -578 | -37.5 | 0 | Feb 13, 2023 | J-GAAP |
Dec, 2023 | 2,493 | -221 | -222 | -175 | -11.3 | 0 | Feb 13, 2024 | J-GAAP |
Dec, 2024 | 2,961 | 76 | 91 | 155 | 10.0 | 0 | Feb 12, 2025 | J-GAAP |
YoY | +18.8% | - | - | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Guidance | 2,950 | 60 | 70 | 110 | 7.1 | 0 | Nov 11, 2024 | J-GAAP |
Dec, 2024 Results | 2,961 | 76 | 91 | 155 | 10.0 | 0 | Feb 12, 2025 | J-GAAP |
Revision Rate | +0.4% | +26.7% | +30.0% | +40.9% | +41.4% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Jun, 2024 | 1,439 | 108 | 111 | 144 | 9.3 | 0 | Aug 9, 2024 | J-GAAP |
Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 12, 2025 | J-GAAP |
YoY | - | - | - | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2023 | 2,493 | -221 | -222 | -175 | -11.3 | 0 | Feb 13, 2024 | J-GAAP |
Dec, 2024 | 2,961 | 76 | 91 | 155 | 10.0 | 0 | Feb 12, 2025 | J-GAAP |
Dec, 2025 Guidance | 3,340 | 160 | 160 | 280 | 18.1 | 0 | Feb 12, 2025 | J-GAAP |
YoY | +12.8% | +110.5% | +75.8% | +80.6% | +81.5% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 699 | -85 | -88 | -73 | -4.7 | -12.2 | Feb 13, 2024 | J-GAAP |
Jan - Mar, 2024 | 704 | 59 | 61 | 75 | 4.9 | 8.4 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 735 | 49 | 50 | 69 | 4.5 | 6.7 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 750 | 1 | 3 | 21 | 1.4 | 0.1 | Nov 11, 2024 | J-GAAP |
Oct - Dec, 2024 | 772 | -33 | -23 | -10 | -0.6 | -4.3 | Feb 12, 2025 | J-GAAP |
YoY | +10.4% | +61.2% | +73.9% | +86.3% | +86.4% |
Related Articles
GMO Financial Gate, Oct-Dec (1Q) Net Income Increases by 90%
JSH, The Current Fiscal Year Ordinary Profit Revised Downward by 4%
PCI Holdings, Oct-Dec (1Q) Ordinary Profit Increases by 67%
Japan Display, The Current Fiscal Year Net Income Loss Widened in Downward Revision, 72% Deficit Against Net Assets
eREX, Oct-Dec (3Q) Net Income Turns to Profit, The Undetermined Dividend Set at 11 yen, Resuming Dividends for the First Time in Two Terms
I-ne, 8% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term, Dividend Raised by 0.5 yen
Recovery International, 1% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term
FUSO DENTSU, Oct-Dec (1Q) Ordinary Profit Decreases by 6%
C.I. MEDICAL, 63% Increase in Ordinary Profit for The Current Fiscal Year
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow